{
    "eid": "2-s2.0-84941660298",
    "title": "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
    "cover-date": "2015-08-18",
    "subject-areas": [
        {
            "$": "Biological Psychiatry",
            "@code": "2803"
        },
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        }
    ],
    "keywords": [
        "chemokines",
        "cytokines",
        "neuroinflammation",
        "schizophrenia",
        "treatment resistance"
    ],
    "authors": [
        "Cristiano Noto"
    ],
    "citedby-count": 77,
    "ref-count": 54,
    "ref-list": [
        "Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-\u03b1",
        "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia",
        "Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia",
        "Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia",
        "Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome",
        "Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia",
        "Abnormalities in serum chemokine levels in euthymic patients with Bipolar Disorder",
        "Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "Understanding the role of inflammatory-related pathways in the pathophysiology and treatment of psychiatric disorders: Evidence from human peripheral studies and CNS studies",
        "Cytokines in schizophrenia and the effects of antipsychotic drugs",
        "IFN-\u03b3-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking",
        "Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission",
        "Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration",
        "Peripheral chemokine levels in women with recurrent major depression with suicidal ideation",
        "Reproducibility of serum cytokines and growth factors",
        "Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis",
        "Similar immune profile in bipolar disorder and schizophrenia: Selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor",
        "Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder",
        "Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics",
        "The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs",
        "Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-\u03b3 and interleukin-10",
        "Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor",
        "Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: Effects of antipsychotic drugs",
        "Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects",
        "Cytokines and schizophrenia: Microglia hypothesis of schizophrenia",
        "Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: Effects of clozapine treatment",
        "Chemokines in the cerebrospinal fluid of patients with active and stable relapsing-remitting multiple sclerosis",
        "MCP-1 gene (SCYA2) and schizophrenia: A case-control association study",
        "Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia",
        "Association of biomarkers and depressive symptoms in schizophrenia",
        "Effects of risperidone on cytokine profile in drug-na\u00efve first-episode psychosis",
        "Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis",
        "Detection of macrophage inflammatory protein (MIP)-1\u03b1 and MIP-1\u03b2 during experimental endotoxemia and human sepsis",
        "Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines",
        "Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity",
        "Plasma levels of cytokines and soluble cytokine receptors during treatment with haloperidol",
        "Effects of clozapine on plasma cytokine and soluble cytokine receptor levels",
        "Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review",
        "Eotaxin and eosinophil recruitment: Implications for human disease",
        "Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls",
        "Current status of chemokines in the adult CNS",
        "Chemokines: A new class of neuromodulator?",
        "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression",
        "Biological insights from 108 schizophrenia-associated genetic loci",
        "The Th2-hypothesis of schizophrenia: A strategy to identify a subgroup of schizophrenia caused by immune mechanisms",
        "The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence",
        "Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies",
        "Increased serum levels of CCL11/eotaxin in schizophrenia",
        "Antipsychotics' effects on blood levels of cytokines in schizophrenia: A meta-analysis",
        "Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis",
        "Elevated interleukin-6 in schizophrenia",
        "Neuroimaging and treatment evidence for clinical staging in psychotic disorders: From the at-risk mental state to chronic schizophrenia",
        "Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology"
    ],
    "affiliation": [
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Belo Horizonte",
            "affilname": "Universidade Federal de Minas Gerais",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": []
}